COST-EFFECTIVENESS OF AN ADHERENCE-ENHANCING INTERVENTION FOR PATIENTS WITH GOUT BASED ON REAL-WORLD DATA

被引：0
|
作者：
Lin, L. W. [1 ]
Teng, G. G. [2 ]
Lim, A. Y. [2 ]
Yoong, J. S. [1 ]
Wee, H. L. [1 ]
机构：
[1] Natl Univ Singapore, Singapore, Singapore
[2] Natl Univ Hlth Syst, Singapore, Singapore
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.014
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CE2
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of an adherence-enhancing intervention for gout based on real-world data
    Lin, Lydia Wenxin
    Teng, Gim Gee
    Lim, Anita Yee Nah
    Yoong, Joanne Su-Yin
    Zethraeus, Niklas
    Wee, Hwee-Lin
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (04) : 545 - 554
  • [2] Within-Trial Cost-Effectiveness of an Adherence-Enhancing Educational Intervention for Glaucoma
    Williams, Andrew M.
    Theophanous, Christos
    Muir, Kelly W.
    Rosdahl, Jullia A.
    Woolson, Sandra
    Olsen, Maren
    Bosworth, Hayden B.
    Hung, Anna
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 244 : 216 - 227
  • [3] Cost-effectiveness of adherence-enhancing interventions: a systematic review
    Simon-Tuval, Tzahit
    Neumann, Peter J.
    Greenberg, Dan
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (01) : 67 - 84
  • [4] Cost-effectiveness of adherence-enhancing interventions: A quality assessment of the evidence
    Elliott, RA
    Barber, N
    Horne, R
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (03) : 508 - 515
  • [5] THE BURDEN OF NON-ADHERENCE WITH ORAL BISPHOSPHONATES AND THE POTENTIAL COST-EFFECTIVENESS OF ADHERENCE-ENHANCING INTERVENTIONS
    Hiligsmann, M.
    Rabenda, V.
    Bruyere, O.
    Reginster, J. Y.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 381 - 382
  • [6] Cost-effectiveness of etanercept and infliximab in the real-world setting - An estimate based on published german data on response and adherence
    Ekelund, M.
    Deeg, M.
    Runge, C.
    VALUE IN HEALTH, 2007, 10 (03) : A1 - A1
  • [7] Personalising adherence-enhancing interventions using a smart inhaler in patients with COPD: an exploratory cost-effectiveness analysis
    Job F. M. van Boven
    Breda Cushen
    Imran Sulaiman
    Garrett Greene
    Elaine MacHale
    Matshediso C. Mokoka
    Frank Doyle
    Richard B. Reilly
    Kathleen Bennett
    Richard W. Costello
    npj Primary Care Respiratory Medicine, 28
  • [8] Personalising adherence-enhancing interventions using a smart inhaler in patients with COPD: an exploratory cost-effectiveness analysis
    van Boven, Job F. M.
    Cushen, Breda
    Sulaiman, Imran
    Greene, Garrett
    MacHale, Elaine
    Mokoka, Matshediso C.
    Doyle, Frank
    Reilly, Richard B.
    Bennett, Kathleen
    Costello, Richard W.
    NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2018, 28
  • [9] Cost-effectiveness analysis of fosnetupitant in patients receiving cisplatin in Japan: analysis based on real-world data
    Hiroshi Inano
    Yoshihito Morimoto
    Kanata Kitagawa
    Akito Shibuya
    Kozue Nakagomi
    Tomohiro Ota
    Yuri Anzo
    Rika Miyauchi
    Aiko Shono
    Kazuhiro Watanabe
    Katsuya Otori
    Supportive Care in Cancer, 2025, 33 (2)
  • [10] Cost-Effectiveness of Tiotropium in Elderly Patients with Severe Asthma Using Real-World Data
    Hong, Sung-Hyun
    Cho, Jeong-Yeon
    Kim, Tae-Bum
    Lee, Eui-Kyung
    Kwon, Sun-Hong
    Shin, Ju-Young
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (05): : 1939 - +
12345